Apnimed to Present at World Sleep Virtual Conference

– Luigi Taranto Montemurro, M.D., company’s Medical Director to discuss pharmacotherapy options for OSA – CAMBRIDGE, Mass. November 30, 2020 – Apnimed, a clinical-stage pharmaceutical company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA)...

Apnimed Further Strengthens Leadership Team and Board of Directors

– Seasoned finance executive Michael Rogers joins as company’s Chief Financial Officer –– Former Biotech CEO and senior Merck executive James (Jay) Galeota joins Board of Directors – CAMBRIDGE, Mass. November 10, 2020 – Apnimed, a clinical-stage pharmaceutical...